The Board of Dishman Pharmaceuticals and Chemicals has given its approval to the amalgamation of Dishman Care Ltd (DCL), a wholly owned subsidiary, with the company.
Dishman Pharmaceuticals and Chemicals Ltd (DPCL) said in a BSE filing that the board has also given approval to amalgamation of the firm with Carbogen Amcis India Ltd (CAIL), its subsidiary.
DPCL, in a separate filing said that the approval has also been accorded by the board on bonus issue of equity shares in the ratio of one equity share for every one equity share held in the company.
It further added that the total consideration for transfer of the ETP undertaking shall be Rs 15 crore.
